These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
    Author: Juergensen PH, Finkelstein FO, Cooper K, Santacroce S, Kliger AS.
    Journal: Adv Perit Dial; 1993; 9():257-9. PubMed ID: 8105938.
    Abstract:
    Hyperparathyroidism remains a cause of significant morbidity in dialysis patients. We studied pulse oral calcitriol, 5.0 micrograms biweekly to control hyperparathyroidism in 12 continuous ambulatory peritoneal dialysis (CAPD) patients. Parathyroid hormone (PTH) levels fell, while calcium and phosphorus levels remained in good control. Pulse oral calcitriol is an effective therapy for hyperparathyroidism in CAPD patients.
    [Abstract] [Full Text] [Related] [New Search]